Friday, March 24, 2017 12:48:05 AM
I'm convinced that the company should have placed a percentage (%) on the efficacy test. By not doing so, it gave the impression (which becomes reality) that they are not done testing. Another reason for not disclosing is not to tip competitors until they are ready to release full disclosure including full blown patent.
I read the claims off some posters indicating the company only put $30K in research while other companies spend millions. Well, if the company is being manage properly, as they have shown by the deals the made for financing, you want them to spend what is necessary, not over spend. This is actually a great sign as they know what they are looking for and not throwing darts.
I'm vey happy with my INVESTMENT (not trade, not flip). If any of you doubts if you should jump in or not because this ticker left penny land, don't doubt. I am sure that you or me would have purchase at $15 per share if we knew it would be today. A properly manage company is worth a lot more that a big company that missuses shareholders capital. Be happy management is conservative with their spending to accomplish GREAT and SIGNIFICANT goals.
GLTA
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM